Am I a Good Candidate for Breast Augmentation? A Complete Guide

A good candidate for breast augmentation is a physically healthy adult with realistic expectations who wants to increase breast volume, improve breast shape, restore fullness lost after pregnancy or weight loss, or correct asymmetry. You should be a non-smoker — or willing to stop smoking for at least four weeks before and after surgery — at a stable weight, not currently pregnant or breastfeeding, and free from active breast disease or medical conditions that significantly impair wound healing. Final candidacy is determined by physical examination and medical history review during consultation, not by any checklist.

Why Candidacy Assessment Matters

Candidacy for breast augmentation is not a binary pass or fail. It is a clinical assessment that considers your overall health, your anatomy, your goals, and the realistic outcomes achievable for your specific situation. A surgeon who assesses every patient as a suitable candidate without meaningful evaluation is not practising candidacy assessment — they are processing bookings. The distinction matters because operating on patients who are not suitable candidates produces the highest rates of complications, revision surgery, and patient dissatisfaction in breast augmentation.

Understanding what surgeons assess and why helps you approach a consultation with relevant information already organised. It also helps you identify whether the consultation you receive is genuinely evaluative — which it should be — or primarily commercial. This guide covers the full candidacy picture: the factors that support suitability, those that require consideration or delay, and the absolute contraindications that preclude surgery regardless of patient preference.

Age and Physical Maturity

International guidelines recommend that patients be at least 18 years of age for saline implants and 22 years of age for silicone implants. These thresholds exist because breast tissue continues developing into early adulthood, and operating before development is complete can affect long-term results and revision requirements. In practice, most experienced surgeons prefer patients to be in their early twenties before proceeding with silicone augmentation to ensure breast development is complete.

Age thresholds are minimum standards, not automatic qualifications. A physically mature adult of 22 who has not yet completed significant life events that affect breast volume — pregnancy, significant weight change — requires different counselling than a patient of 35 whose body and weight have been stable for years. The discussion of timing is particularly relevant for patients who are planning future pregnancies, as pregnancy causes significant changes in breast volume and skin elasticity that can materially affect the long-term appearance of augmented breasts.

There is no upper age limit for breast augmentation. Patients in their forties, fifties, and beyond routinely undergo breast augmentation with good outcomes. What changes with age is the pre-operative assessment — older patients are more likely to require additional cardiovascular screening before general anaesthesia and are more likely to have relevant medical history that requires assessment. The presence of age-related tissue changes, including reduced skin elasticity and altered breast tissue composition, also influences implant selection and the discussion of realistic outcomes.

Physical Health Requirements

Breast augmentation is an elective procedure performed under general anaesthesia. Candidates must be in sufficiently good physical health to safely undergo general anaesthesia and to heal from surgery without significant complication. This means being free from uncontrolled systemic disease, having no active infection at any site, and having medical conditions that do affect surgery — such as controlled hypertension or well-managed diabetes — disclosed and assessed by the surgical team before proceeding.

Cardiovascular Health

General anaesthesia places demands on the cardiovascular system. Patients with well-controlled hypertension, stable coronary artery disease, or other managed cardiac conditions can often undergo elective surgery safely, subject to pre-operative assessment and — in some cases — clearance from a cardiologist. Uncontrolled hypertension, recent cardiac events, or unstable cardiac conditions are contraindications to elective surgery and must be addressed before augmentation is considered. Your anaesthesiologist will review your cardiovascular history as part of the pre-operative assessment.

Diabetes

Well-controlled diabetes is not an absolute contraindication to breast augmentation, but it requires careful pre-operative assessment. Diabetes impairs wound healing and increases infection risk — both of which are directly relevant to breast augmentation recovery. HbA1c levels — a measure of blood sugar control over the preceding 3 months — are typically assessed before surgery. Poorly controlled diabetes, reflected in elevated HbA1c, significantly increases surgical risk and is generally a reason to delay surgery until control is improved. Patients with well-controlled diabetes managed with diet, oral medication, or insulin can proceed with surgery in most cases, with appropriate perioperative management.

Autoimmune Conditions

Autoimmune conditions — including rheumatoid arthritis, lupus, Sjögren’s syndrome, and scleroderma — require specific assessment before breast augmentation. These conditions affect wound healing, infection susceptibility, and the body’s response to foreign materials including implants. Some autoimmune conditions and the medications used to treat them — particularly immunosuppressants and corticosteroids — significantly increase surgical risk and complication rates. The assessment of a patient with an autoimmune condition requires close coordination between the plastic surgeon and the rheumatologist managing the underlying condition. It is not an automatic contraindication but it is a significant consideration that requires specialist input.

Bleeding Disorders and Anticoagulation

Patients with bleeding disorders or those taking anticoagulant medications — warfarin, direct oral anticoagulants, low-molecular-weight heparin — require specific pre-operative management. Anticoagulation for conditions such as atrial fibrillation, mechanical heart valves, or previous DVT cannot simply be stopped before surgery without clinical assessment of the bridging strategy. This requires coordination between the plastic surgeon, the prescribing physician, and the anaesthesiologist. It is not an automatic contraindication but it significantly complicates pre-operative planning and must be disclosed fully at consultation.

Weight Stability

Candidates for breast augmentation should be at a stable weight — ideally within their normal weight range and not actively gaining or losing significant weight. Significant weight fluctuation after augmentation changes breast volume and skin tension, affecting the appearance of the implants and potentially requiring revision. Patients who are significantly overweight are at higher anaesthetic and surgical risk and may be advised to reach a more appropriate weight before proceeding.

The relationship between weight and breast augmentation candidacy operates in both directions. Patients who are significantly underweight may have insufficient natural breast tissue to adequately cover implants — particularly in subglandular placement — increasing the risk of visible rippling, implant edge palpability, and an unnatural result. Patients who are significantly overweight carry higher risks of wound healing complications, infection, DVT, and anaesthesia-related events. Neither extreme represents an absolute contraindication, but both require honest discussion of the modified risk profile.

Patients who are planning significant weight loss — through diet and exercise, or through bariatric surgery — are generally advised to complete their weight loss journey and allow their weight to stabilise for at least 6 to 12 months before undergoing breast augmentation. Augmentation performed on a body that subsequently undergoes significant volume change will produce a different result from what was achieved at surgery — sometimes significantly so. Sequencing weight loss before augmentation rather than after produces more predictable and durable outcomes.

Smoking Status

Smoking is one of the most significant modifiable risk factors for surgical complications. Nicotine causes vasoconstriction — narrowing of blood vessels — which directly reduces tissue oxygenation at the wound site. The consequences include impaired wound healing, higher infection rates, increased risk of capsular contracture, greater likelihood of wound breakdown, and slower overall recovery. These effects are dose-dependent and present even in light smokers.

Most surgeons require patients to stop smoking for a minimum of 4 weeks before surgery and to remain smoke-free for at least 4 weeks after. This is not a preference — it is a clinical standard supported by evidence of meaningfully better outcomes in non-smoking patients. Nicotine replacement products — patches, gum, lozenges — also contain nicotine and produce the same vasoconstriction effect. Patients using nicotine replacement should discuss this with their surgeon as the cessation requirement applies to all nicotine sources, not cigarettes alone.

Patients who smoke and are unwilling to stop for the required period are not suitable candidates for elective breast augmentation at that time. Proceeding with a known, modifiable, significant risk factor in place when the patient has declined to address it is not consistent with responsible surgical practice.

Pregnancy and Breastfeeding

Breast augmentation should not be performed during pregnancy under any circumstances. The physiological changes of pregnancy — including significant increases in breast volume, changes in blood supply, and hormonal effects on tissue — make surgery both higher risk and the outcome unpredictable. Additionally, general anaesthesia carries risks for the foetus at all stages of pregnancy.

Patients who are currently breastfeeding should wait until breastfeeding has fully ceased and the breasts have returned to their pre-breastfeeding state before undergoing augmentation — typically a minimum of 3 to 6 months after breastfeeding stops. This waiting period allows breast volume to stabilise, which is necessary for accurate implant sizing and pocket planning. Operating before the breast has returned to its baseline volume produces results that change as the residual breastfeeding-related changes resolve.

Patients who have recently completed pregnancy and breastfeeding and are considering augmentation to restore lost volume should also be at a stable weight and have allowed sufficient time for breast tissue to stabilise. The consultation timing matters — a surgeon assessing you 6 weeks after breastfeeding stops is assessing a breast in a state of transition, not its settled baseline. A minimum of 3 to 6 months post-breastfeeding is the generally recommended interval before consultation for augmentation.

Breast Health and Screening Status

Candidates for breast augmentation should be free from active breast disease. Any unresolved breast lump, abnormal mammogram result, nipple discharge, or ongoing investigation of a breast abnormality must be fully resolved before augmentation proceeds. Patients who are within age-appropriate breast cancer screening programmes should be current with their screening before surgery. A history of breast cancer requires specialist assessment involving both the oncologist and the plastic surgeon before augmentation is considered.

Pre-operative breast imaging — mammography or ultrasound — is recommended for patients over 40 before augmentation surgery and for younger patients with a significant family history of breast cancer or other clinical indications. The purpose is to establish a baseline of breast tissue appearance before implants are in place, which facilitates future screening interpretation and documents the absence of pre-existing abnormality before the surgical change.

Patients with a known BRCA1 or BRCA2 mutation, a strong family history of breast or ovarian cancer, or who are under surveillance for elevated breast cancer risk require discussion with their oncologist or breast specialist before proceeding with augmentation. The primary consideration is not that augmentation increases cancer risk — there is no evidence that it does — but that implants affect mammography technique and may complicate the surveillance programme appropriate for high-risk patients. In some cases the timing of augmentation may need to be coordinated with the surveillance plan.

Psychological Readiness and Motivation

Psychological readiness for breast augmentation involves having realistic expectations about outcomes, pursuing the procedure for personal rather than external reasons, being in a stable emotional state, and understanding the long-term commitment that implants represent. Patients who are seeking surgery primarily to meet another person’s preferences, who are in acute psychological distress, or who expect the procedure to resolve significant self-esteem or relationship difficulties are not in an optimal position to make a durable elective surgical decision.

Realistic expectations are one of the most consistently cited predictors of patient satisfaction after breast augmentation. Patients who understand what the procedure can and cannot achieve — who have seen before-and-after photographs of outcomes on patients with similar anatomy, who have discussed the outcome range honestly with their surgeon, and who have accepted that perfection and complete symmetry are not surgical guarantees — have materially better reported satisfaction than those whose expectations were not calibrated before surgery.

Body dysmorphic disorder (BDD) — a condition characterised by excessive preoccupation with a perceived physical defect — is a recognised contraindication to elective cosmetic surgery. Patients with BDD typically experience little or no satisfaction with surgical outcomes regardless of the technical quality of the result, and surgery frequently exacerbates rather than resolves the underlying preoccupation. Experienced surgeons screen for BDD indicators during consultation — including disproportionate distress relative to the degree of the perceived concern, a history of multiple cosmetic procedures without satisfaction, and focus on minute details that others cannot perceive. Identification of BDD indicators is a reason to refer for psychological assessment before any surgical discussion continues.

Anatomical Factors That Influence Candidacy

Beyond general health and psychological readiness, specific anatomical characteristics influence both candidacy and the approach to surgery:

Chest wall shape — a convex or concave (pectus excavatum) chest wall affects how the implant sits and which placement approach provides the most natural result. Significant chest wall asymmetry may limit the degree of symmetry achievable surgically and should be discussed in detail during consultation.

Existing breast asymmetry — natural asymmetry between the two breasts is present in virtually all patients. Moderate to significant asymmetry — in volume, shape, nipple position, or inframammary fold height — can be improved with augmentation using different implant sizes on each side, but cannot always be fully corrected. Patients with significant asymmetry should have explicit discussion of the expected degree of improvement and the residual asymmetry that may remain.

Skin elasticity and tissue quality — thin skin with limited natural breast tissue coverage constrains implant size selection and placement options, and increases the risk of visible rippling and implant edge palpability. This is a particularly relevant consideration for very slim patients requesting large implants — the anatomical constraints of thin coverage may make the requested size inappropriate regardless of patient preference.

Nipple and areola position — significant nipple ptosis (downward pointing of the nipple below the inframammary fold) is not corrected by augmentation alone and may require a concurrent or staged breast lift. Augmenting a breast with significant ptosis without addressing the nipple position typically produces an outcome described as a “Snoopy deformity” — the implant fills the upper breast while the nipple and lower breast tissue hang below it. Patients with ptosis require honest discussion of whether augmentation alone is appropriate for their anatomy or whether a combined procedure is indicated.

Factors That Require Delay Rather Than Permanent Exclusion

Several factors make augmentation inadvisable at a specific point in time without permanently excluding a patient from candidacy:

Active infection anywhere in the body — dental abscess, urinary tract infection, skin infection — increases the risk of haematogenous spread to the implant pocket and should be fully resolved before surgery proceeds.

Recent significant weight change — augmentation should be deferred until weight has been stable for at least 6 to 12 months.

Recent pregnancy or current breastfeeding — as discussed above, a minimum waiting period of 3 to 6 months after breastfeeding cessation is recommended.

Planned significant weight loss — including bariatric surgery — should ideally be completed and the weight stabilised before augmentation.

Uncontrolled medical conditions — diabetes, hypertension, autoimmune disease — should be optimised before elective surgery is scheduled.

Active smoking — cessation for a minimum of 4 weeks before and after surgery is required. Scheduling surgery before this cessation period has been completed is premature.

Acute psychological distress — major life events, bereavement, relationship breakdown, or acute mental health episodes are not an ideal context for making an elective surgical decision. A period of stability is appropriate before proceeding.

Absolute Contraindications

The following represent situations in which breast augmentation should not proceed regardless of patient preference:

Active or incompletely treated breast cancer — augmentation in the context of active breast malignancy is not appropriate outside of specifically planned reconstructive contexts under oncological supervision.

Pregnancy — at any stage.

Uncontrolled systemic disease that makes general anaesthesia unsafe — including severe uncontrolled cardiac or respiratory disease.

Active body dysmorphic disorder — identified through appropriate screening during consultation.

Inability to provide informed consent — due to cognitive impairment or acute psychological incapacity.

The Bottom Line

Candidacy for breast augmentation is determined by the intersection of your physical health, your anatomy, your goals, and the realistic outcomes achievable at this point in your life. Most adults who want breast augmentation and are in reasonable health are suitable candidates — the procedure is one of the most commonly performed and well-studied in cosmetic surgery. But suitability is not universal, and the factors that make it appropriate or inadvisable for a specific individual can only be assessed properly through a physical consultation with a qualified surgeon.

If you have specific health conditions, circumstances, or concerns that you are not sure are relevant — bring them to the consultation anyway. Disclosing everything and having your surgeon tell you it is not a concern is a better outcome than omitting something relevant and having it affect your surgical plan or recovery. The candidacy assessment is the foundation of everything that follows. A thorough one, conducted honestly by a qualified surgeon, is what protects your outcome before the procedure begins.